News/Events
Funding award to develop minimally invasive tools to improve cancer surgery
A device to help treat tumours in the liver has received a £1 million Government grant.Read more
Punctured lung affects almost one in a hundred hospitalised COVID-19 patients
As many as one in 100 patients admitted to hospital with COVID-19 develop a pneumothorax – a ‘punctured lung’ according to a study supported by the NIHR Cambridge BRC. Read more
New model predicts oesophageal cancer eight years early for one in two patients
DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis.Read more
New research shows steroid improves survival of critically ill Covid-19 patients
New research published has been able to show that using the steroid hydrocortisone on patients with severe COVID-19 symptoms improves their recovery.Read more
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients
Cambridge University Hospitals has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.Read more
Gold medal for Professor Gordon Dougan
Professor Gordon Dougan has been awarded the Albert B. Sabin Gold Medal. The award is given to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field.Read more
Transgender and gender-diverse individuals are more likely to be autistic and report higher autistic traits
Transgender and gender-diverse adults are three to six times more likely as cisgender adults to be diagnosed as autistic, according to a new Cambridge study.Read more
New NHS service enables people to sign up to be contacted for COVID-19 vaccine studies
A new NHS service has been launched, helping people across the UK sign up for information on the new COVID-19 vaccine trials.Read more
Sponge on a string test to transform oesophageal cancer diagnosis
A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according new research. Read more
New funding boost to speed up diagnosis in oesophageal cancer
Cambridge will lead on improving early detection in oesophageal cancer as part of a Government backed projectRead more
National research platform launches new website
The address is the same, but the next time you visit the NIHR BioResource website, you’ll see it has a brand new look, ready for researchers and the public.Read more
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19
As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more
Phased re-start of non-COVID-19 research
In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more
Rapid COVID-19 test halves patient waiting times
A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more
Cambridgeshire Trusts join COVID-19 vaccine trial
Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more
POPStar study launches to investigate how pregnancy data can predict future health
A new study from the Departments of Obstetrics & Gynaecology and Paediatrics at the University of Cambridge is investigating how conditions in the womb can predict the future health of mothers and their children.Read more
Prestigious fellowship election for NIHR Cambridge BRC researchers
The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more
Cambridge trial targets immune response to treat COVID-19 patients
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more
Discover more about the NIHR Cambridge BRC
Contact us by phone, email or web for more information.
Events Calendar
Listing relevant events and training sessions for researchers and members of the public.